The liver immune status index (LISI) demonstrated strong predictive capabilities for postoperative outcomes in hepatocellular carcinoma (HCC) patients, particularly with vascular invasion. In a study of 1,337 hepatectomies, LISI effectively stratified patients into distinct risk groups, correlating significantly with established prognostic markers. Notably, LISI provided superior predictive performance for two-year overall survival and recurrence rates. The HISCO-HCC score, which integrates LISI, tumor burden score, and alpha-fetoprotein, further augments prognostic precision, aiding personalized patient care.
Journal Article by Imaoka Y, Ohira M (…) Ohdan H et 10 al. in J Hepatobiliary Pancreat Sci
© 2024 The Author(s). Journal of Hepato‐Biliary‐Pancreatic Sciences published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Hepato‐Biliary‐Pancreatic Surgery.